Thermo Fisher Scientific is reinforcing its commitment to China as the country emerges as an increasingly important source of ...

DUALITYBIO Inc. announced that it has entered into a collaboration and license agreement with Genentech, a member of the ...

METHOD IN BRIEF Cost-of-goods figures in this article are reconstructions, not disclosures. No company supplied a ...

In July, Samsung Biologics announced an all-cash offer to acquire PolyPeptide Group for CHF 1.46 billion (approximately KRW 2 ...

Pivotal trial will evaluate the HER2-targeted ADC biosimilar against Roche’s Kadcyla, advancing Formosa Pharmaceuticals and ...

Sanyou Biopharmaceuticals Co., Ltd. (hereinafter referred to as "Sanyou Bio"), announced the official launch of Clicklinks, ...

Memorandum of Understanding establishes a framework for joint development of clinical trial simulation capabilities; The ...

Designation supports the global development of RTX-117 and may provide potential future access to a transferable Priority ...

Biosidus, an Argentine biotechnology company with more than four decades of experience in the development and manufacturing ...

U.S. IRB Approval for Pivotal Phase 3 Trial SUPREME-01 (CBL-0301)—The protocol amendment for the pivotal Phase 3 clinical ...

Multi-country projects across Africa and Asia leverage alternative sample collection and advanced metabolomics to accelerate ...

New paradigm integrates single-cell transcriptomics, regulatory network inference, and AI to decode—and therapeutically ...